Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- In-licensing
- View
Partners/companies looking for a strategic partnership to give them privileged access to hospital markets in Europe.
LFB is seeking partners/companies which are looking for a strategic partnership to give them privileged access to hospital markets in Europe, ideally having a synergistic presence in North America or South East Asia.
Full description
LFB’s reputation and expertise has earned it access to Europe’s top hospital markets, LFB is currently the 3rd largest supplier to France’s hospitals.
A partnership therefore with LFB, would provide the contacts and the ability to access the hospital markets of Europe, particularly in the areas of immunology, coagulation disorders and haemophilia, intensive care – onco-hematology - more generally orphan drugs.
Development status
Phase III/IV
Type of business relationship sought
LFB is seeking partners/companies looking for a strategic partnership in Europe, starting with key markets such as France, Germany and the UK.
Licensing contact
Marc Pennacino
Business Development Director
Business Development Director
More information
For more information about the product please visit website.
Company details
LFB SA
LFB is a fully integrated pharmaceutical company exclusively dedicated to therapeutic proteins. LFB has developed a proprietary platform to create and develop highly cytotoxic MAb's
LFB is a fully integrated pharmaceutical company exclusively dedicated to therapeutic proteins. LFB has developed a proprietary platform to create and develop highly cytotoxic MAb's
Related reports
Are you looking for reports related to this particular subject. Our Reports section is the best place to start.
Related items
- Seeking in-licensing opportunities in haematology
- Hospital Pharmaceutical Products
- UK Marketing Partner
- Acquisition of established pharmaceuticals in the UK / Irish market
- Seeking in licensing opportunities for Europe with a priority for France, Germany and UK for products ready to market in hospitals or under clinical development
Related categories
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us